May 22

This nasal spray stops med-resistant depression in trials

Posted in: Today's Chili

The nasal spray medication called Esketamine was approved by the FDA this year for treatment of drug-resistant depression – and we’ve done a bit of an investigation. Over 17.3-million adults in the United States suffer from depression – that’s over 7% of all US adults. It’s safe to say this affliction affects the way we live our lives – and … Continue reading

No Responses to “This nasal spray stops med-resistant depression in trials”

Post a Comment